BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1656 related articles for article (PubMed ID: 18661411)

  • 1. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
    Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent mesangial IgA nephritis following renal transplantation.
    Odum J; Peh CA; Clarkson AR; Bannister KM; Seymour AE; Gillis D; Thomas AC; Mathew TH; Woodroffe AJ
    Nephrol Dial Transplant; 1994; 9(3):309-12. PubMed ID: 8052439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of IgA nephropathy with crescents in kidney transplants.
    Mousson C; Charon-Barra C; Funes de la Vega M; Tanter Y; Justrabo E; Martin L; Rifle G
    Transplant Proc; 2007 Oct; 39(8):2595-6. PubMed ID: 17954186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
    Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT
    Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
    Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy.
    Jeong HJ; Kim YS; Kwon KH; Kim SI; Kim MS; Choi KH; Lee HY; Han DS; Park K
    Pathol Int; 2004 Nov; 54(11):837-42. PubMed ID: 15533226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy with crescents in kidney transplant recipients.
    Kowalewska J; Yuan S; Sustento-Reodica N; Nicosia RF; Smith KD; Davis CL; Alpers CE
    Am J Kidney Dis; 2005 Jan; 45(1):167-75. PubMed ID: 15696457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
    Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
    Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
    Takao T; Hatori M; Ichimaru N; Honda M; Nonomura N; Matsumiya K; Kokado Y; Takahara S; Okuyama A; Miyamoto M; Yokoyama K; Imai E; Kyo M
    Hinyokika Kiyo; 1997 Sep; 43(9):661-4. PubMed ID: 9365847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of IgA nephropathy after renal transplantation.
    van der Boog PJ; de Fijter JW; Bruijn JA; van Es LA
    Ann Med Interne (Paris); 1999 Feb; 150(2):137-42. PubMed ID: 10392262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.